Neubotulinum Toxin Injection in Cerivical Dystonia
Status:
Completed
Trial end date:
2021-05-30
Target enrollment:
Participant gender:
Summary
24-Week Prospective, Double-Blinded, Randomized, Cross-over design in Multicenter Study of 50
unit of Neubotulinum Toxin Type A (Neuronox) and 100 unit of Neubotulinum Toxin Type A
(Neuronox) injection for Cervical Dystonia in patient diagnosed with cervical dystonia
according to clinical diagnosis. It was designed to evaluate the efficacy, safety,
tolerability, quality of life and the comparesion the improvement after treatment by of 50
unit of Neubotulinum Toxin Type A (Neuronox) and 100 unit of Neubotulinum Toxin Type A
(Neuronox) injection.